BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Dec. 15, 2004
View Archived Issues
MediGene's Phase III Drug Effective In Genital Warts
MUNICH, Germany - MediGene AG completed its second Phase III trial of Polyphenon E, a treatment for genital warts, getting significant clinical effects compared to placebo, as well as good tolerability. (BioWorld International)
Read More
Chroma Raises £5M More To Add To Second Round
Read More
New Antibiotic Class Might Thrash Drug-Resistant TB
Read More
European Report: New Biotech Products Should Rise In Future
Read More
Pepscan Enters Vaccine Deal Aimed At Cytokine With Cytos
Read More
ExonHit Hits First Milestone In Partnership With Allergan
Read More
Cresset Using FieldScreen As Drug Discovery Platform
Read More
Other News To Note
Read More